Kissei Pharmaceutical Co., Ltd. (OTCMKTS:KSPHF – Get Rating) was the recipient of a large decrease in short interest in the month of February. As of February 15th, there was short interest totalling 35,300 shares, a decrease of 11.3% from the January 31st total of 39,800 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is currently 353.0 days.
Kissei Pharmaceutical Price Performance
Shares of OTCMKTS KSPHF opened at $18.81 on Monday. Kissei Pharmaceutical has a 52-week low of $17.71 and a 52-week high of $19.90. The business has a 50-day moving average price of $19.05 and a 200 day moving average price of $17.84.
Get
Kissei Pharmaceutical alerts:
Kissei Pharmaceutical Company Profile
(Get Rating)
Kissei Pharmaceutical Co, Ltd. engages in the research, development, manufacture and sale of pharmaceutical products and health foods. It operates through the following segments: Pharmaceuticals, Information Service, and Others. The Pharmaceuticals segment researches, develops, manufactures, and markets drugs, which are used in the fields of urology, dialysis, women's health, ophthalmology, endocrinology and metabolism.
Featured Stories
- Get a free copy of the StockNews.com research report on Kissei Pharmaceutical (KSPHF)
- MarketBeat Week in Review – 2/27 – 3/3
- The 3 Most Upgraded Stocks Are Reversing
- How to Find Blue Chip Dividend Stocks
- Zscaler, Inc Plummets, Is It Time To Buy The Dip?
- What is a Good Dividend Yield? How to Decide
Receive News & Ratings for Kissei Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kissei Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
2月份空头股数的降幅最大的是启世药业股份有限公司。截至2月15日,空头股数共有3.53万股,较1月31日的3.98万股减少11.3%。以日均百股成交量计算,目前天数与回补比率为353.0天。
Kissei药品价格表现
周一,OTCMKTS KSPHF的股价开盘报18.81美元。Kissei Pharmtics的52周低点为17.71美元,52周高位为19.90美元。该业务的50日移动均线价格为19.05美元,200日移动均线价格为17.84美元。
到达
启世药业警报:
Kissei制药公司简介
(获取评级)
Kissei制药有限公司从事医药产品和保健食品的研究、开发、制造和销售。它通过以下部门运作:制药、信息服务和其他。制药部门研究、开发、制造和营销用于泌尿、透析、妇女健康、眼科、内分泌学和新陈代谢领域的药物。
专题报道
- 免费获取有关Kissei制药公司(KSPHF)的股票新闻网站研究报告
- 市场回顾周-2/27-3/3
- 升幅最大的3只股票正在逆转
- 如何寻找蓝筹股分红股
- Zscaler,Inc.Plummets,是时候去抄底了吗?
- 什么是好的股息收益率?如何决定
获得《Kissei药学日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Kissei Pharmtics和相关公司的最新新闻和分析师评级的每日简要摘要。